| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |